OZANIMOD for Relapsing multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 127 adverse event reports in the FDA FAERS database where OZANIMOD was used for Relapsing multiple sclerosis.
Most Reported Side Effects for OZANIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 707 | 9.0% | 0 | 19 |
| Multiple sclerosis relapse | 567 | 7.2% | 1 | 46 |
| Drug ineffective | 517 | 6.6% | 1 | 25 |
| Headache | 490 | 6.2% | 0 | 16 |
| Dizziness | 329 | 4.2% | 1 | 18 |
| Product dose omission issue | 325 | 4.1% | 0 | 17 |
| Nausea | 267 | 3.4% | 0 | 17 |
| Diarrhoea | 253 | 3.2% | 0 | 15 |
| Colitis ulcerative | 246 | 3.1% | 2 | 47 |
| Pain | 228 | 2.9% | 1 | 15 |
| Back pain | 206 | 2.6% | 0 | 10 |
| Adverse event | 178 | 2.3% | 0 | 13 |
| Fall | 165 | 2.1% | 2 | 19 |
| Multiple sclerosis | 164 | 2.1% | 2 | 9 |
| Covid-19 | 163 | 2.1% | 6 | 49 |
Other Indications for OZANIMOD
Multiple sclerosis (4,291)
Colitis ulcerative (1,802)
Product used for unknown indication (1,372)
Relapsing-remitting multiple sclerosis (138)
Multiple sclerosis relapse (84)
Colitis (78)
Crohn's disease (72)
Proctitis ulcerative (57)
Secondary progressive multiple sclerosis (19)
Clinically isolated syndrome (18)
Other Drugs Used for Relapsing multiple sclerosis
OCRELIZUMAB (6,883)
OFATUMUMAB (3,705)
FINGOLIMOD (851)
GLATIRAMER (375)
ALEMTUZUMAB (350)
SIPONIMOD (194)
INTERFERON BETA-1A (192)
NATALIZUMAB (140)
RITUXIMAB (136)
CLADRIBINE (123)